Neuroimmunology of Huntington's Disease: Revisiting Evidence from Human Studies
about
Tetrahydrocannabinolic acid is a potent PPARγ agonist with neuroprotective activity.Promises and pitfalls of immune-based strategies for Huntington's disease.Translation of MicroRNA-Based Huntingtin-Lowering Therapies from Preclinical Studies to the Clinic.Neurodegenerative Diseases: Regenerative Mechanisms and Novel Therapeutic Approaches
P2860
Neuroimmunology of Huntington's Disease: Revisiting Evidence from Human Studies
description
2016 nî lūn-bûn
@nan
2016 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Neuroimmunology of Huntington's Disease: Revisiting Evidence from Human Studies
@ast
Neuroimmunology of Huntington's Disease: Revisiting Evidence from Human Studies
@en
Neuroimmunology of Huntington's Disease: Revisiting Evidence from Human Studies
@nl
type
label
Neuroimmunology of Huntington's Disease: Revisiting Evidence from Human Studies
@ast
Neuroimmunology of Huntington's Disease: Revisiting Evidence from Human Studies
@en
Neuroimmunology of Huntington's Disease: Revisiting Evidence from Human Studies
@nl
prefLabel
Neuroimmunology of Huntington's Disease: Revisiting Evidence from Human Studies
@ast
Neuroimmunology of Huntington's Disease: Revisiting Evidence from Human Studies
@en
Neuroimmunology of Huntington's Disease: Revisiting Evidence from Human Studies
@nl
P2860
P50
P3181
P356
P1476
Neuroimmunology of Huntington's Disease: Revisiting Evidence from Human Studies
@en
P2093
Erin Furr-Stimming
P2860
P304
P3181
P356
10.1155/2016/8653132
P407
P5008
P577
2016-01-01T00:00:00Z
2016-08-08T00:00:00Z